Abstract OT2-02-02: NRG Oncology/NSABP B-51/RTOG 1304: A phase III clinical trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypN0 after neoadjuvant chemotherapy (NC)
Year: 2016
Type: conference-abstract
Source: Cancer Research
Institutions: Emory Healthcare, The University of Texas MD Anderson Cancer Center, Orlando Health, University of California, Los Angeles, University of Pittsburgh, Yonsei University, Allegheny General Hospital, NRG Oncology, Winship Cancer Institute, Rutgers Cancer Institute, The Ohio State University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2397063245